Prognostic Values for ERG, PTEN, CRISP3, and SPINK1 To Predict Biochemical Recurrence in Prostate Cancer

被引：0
|
作者：
Noh, Byeong-Joo [1 ]
Sung, Ji-Youn [1 ]
Kim, Youn-Wha [1 ]
Chang, Sung-Goo [1 ]
Park, Yong-Koo [1 ]
机构：
[1] Kyung Hee Univ Hosp, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
985
引用
收藏
页码：247A / 248A
页数：2
相关论文
共 50 条
  • [21] Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
    Samir Al Bashir
    Mohammed Alshalalfa
    Samar A Hegazy
    Michael Dolph
    Bryan Donnelly
    Tarek A Bismar
    Journal of Hematology & Oncology, 7
  • [22] Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis
    Al Bashir, Samir
    Alshalalfa, Mohammed
    Hegazy, Samar A.
    Dolph, Michael
    Donnelly, Bryan
    Bismar, Tarek A.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [23] SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion
    Huang, Kuo-Cheng
    Evans, Andrew
    Donnelly, Bryan
    Bismar, Tarek A.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 399 - 407
  • [24] SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development
    Huang, Kuo-Cheng
    Begin, Louis R.
    Palanisamy, Nallasivam
    Donnelly, Bryan
    Bismar, Tarek A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (05) : 235.e1 - 235.e10
  • [25] TMPRSS2:ERG fusion and SPINK1 expression in endocrine treated prostate cancer
    Leinonen, K. A.
    Tolonen, T. T.
    Bracken, H.
    Stenman, U-H.
    Tammela, T. L. J.
    Saramaki, O. R.
    Visakorpi, T.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 : 94 - 94
  • [26] Comparison of ERG and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men
    Koide, Haruhisa
    Kimura, Takahiro
    Inaba, Hiroyuki
    Sato, Shun
    Iwatani, Kosuke
    Yorozu, Takashi
    Furusato, Bungo
    Kamata, Yuko
    Miki, Jun
    Kiyota, Hiroshi
    Takahashi, Hiroyuki
    Egawa, Shin
    PROSTATE, 2019, 79 (01): : 3 - 8
  • [27] Cysteine-Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer with Poorest Clinical Patient's Outcome
    Al-Bashir, S.
    Alshalalfa, M.
    Hegazy, S.
    Dolph, M.
    Donnelly, B.
    Bismar, T.
    LABORATORY INVESTIGATION, 2014, 94 : 213A - 213A
  • [28] Cysteine-Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer with Poorest Clinical Patient's Outcome
    Al-Bashir, S.
    Alshalalfa, M.
    Hegazy, S.
    Dolph, M.
    Donnelly, B.
    Bismar, T.
    MODERN PATHOLOGY, 2014, 27 : 213A - 213A
  • [29] Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis
    Dahlman, Anna
    Rexhepaj, Elton
    Brennan, Donal J.
    Gallagher, William M.
    Gaber, Alexander
    Lindgren, Anna
    Jirstrom, Karin
    Bjartell, Anders
    MODERN PATHOLOGY, 2011, 24 (05) : 708 - 719
  • [30] Differences in TMPRSS2-ERG Gene Fusion, PTEN Deletion, and SPINK1 Overexpression in Prostate Cancer in African-American and Caucasian Men
    Khani, F.
    Mosquera, J. M.
    Park, K.
    Srivastava, A.
    Tewari, A. K.
    Rubin, M. A.
    Robinson, B. D.
    MODERN PATHOLOGY, 2012, 25 : 218A - 218A
12345